According to preliminary consolidated sales results for January 2015, sales of JSC Olainfarm have reached 7.75 million euro, which represents a reduction by 20% compared to January of 2014. The biggest sales increase has been achieved to the UK, where sales have grown by 50%, shipment of almost 55 000 euro has also been made to Brazil. The major sales markets of JSC Olainfarm in January 2015 were Russia, Latvia, Ukraine, The UK and The Netherlands.
|January 2015, consolidated sales||Share in total sales||Changes to January, 2014|
Sales of Latvijas aptieka Ltd. during January were 1.43 million euro and 57 pharmacies were operating during this period. Sales of Silvanols Ltd. during January were 0.39 million euro, which is an increase by 36% compared to January of 2014. During this month Silvanols Ltd. has made sales to five European countries, sales to Georgia have demonstrated particularly strong growth.
According to unconsolidated sales results of JSC Olainfarm for January 2015, the sales of the company were 6.7 million euro, which represents a reduction by 20% compared to the same period one year ago. The biggest sales increases were achieved in Kazakhstan, where sales grew by 141%, the UK, where sales grew by 50% and Latvia, where sales grew by 46%. Major sales markets of JSC Olainfarm during January 2015 were Russia, Latvia, Ukraine, the UK and the Netherlands. In total products of JSC Olainfarm during this period were sold to 20 countries on four continents.
|January 2015, unconsolidated sales||Share in total sales||Changes to January 2014|
According to preliminary estimated made by the Board of the company, the unconsolidated sales of the company in 2015 are expected to be at 84 million euro, while consolidated sales are expected to be at 100 million euro. According to these preliminary sales figures, during January 2015 8% of annual consolidated sales target and 8% of annual unconsolidated sales targets were met.
JSC Olainfarm is one of the biggest pharmaceutical companies in Latvia with more than 40 years of experience in production of medication and chemical and pharmaceutical products. A basic principle of company’s operations is to produce reliable and effective top quality products for Latvia and the rest of the world. Products made by the Group are being exported to more than 35 countries of the world, including the Baltics, Russia, other CIS, Europe, Asia, North America and Australia.
Information prepared by:
Member of the Board
Tel: +371 6 7013 717
Cell: +371 2 6448 873